Farewell and New Beginings

After two transformative years in Premium Genetics, I had to say farewell.
Reflecting on my journey, I have gained invaluable insights into genetics, discovered more about my capabilities, and expanded my knowledge.
During this period, I have had the privilege of collaborating with exceptional colleagues and engaging with experts in both pediatrics and oncology, which has enriched my professional network and experiences.
This departure is not a final goodbye but rather a transition toward a more dedicated advocacy role for patients with rare diseases in the future.

The latest newsletter is here! 

I am eager to channel my time and skills into making a meaningful impact in this crucial area as a patient advocate.

Honoring Dedication on International Women’s Day 2025

This year, I want to celebrate the mothers who have selflessly devoted their time and energy to organizations Hrabriša - Lil` Brave One that support patients with rare neurotransmitter diseases and their families.
Their commitment shows how, even in challenging times, there is still a motivation to provide valuable resources and foster community through the exchange of information, knowledge, and practical advice for the well-being of patients and their families.

Hrabriša - Lil` Brave One

More about this topic is in my previous post HERE.
Also, I've shared some ideas about major topics regarding International Women's Day.

Important milestones in the community of rare diseases

Did you know that achondroplasia is the most common genetic cause of disproportionate short stature, affecting over 360,000 individuals worldwide? This condition is caused by a mutation in the fibroblast growth factor receptor 3 (#FGFR3) gene, which disrupts normal bone growth.
Current treatments in Serbia primarily focus on symptom management, but recent advancements in genetic therapy offer new hope for altering the course of this condition.

Media center, Belgrade, March 2025

I was honored to moderate a panel titled "Achondroplasia and Therapy: Experience, Results, and Perspectives" with distinguished speakers at the forefront of achondroplasia research and treatment.
Their expertise provided valuable insights into the current landscape and future directions of genetic therapies in Serbia.
You can see the recording of our conversation on the Media Center Belgrade YouTube channel HERE.

Embracing Spring and Future Opportunities

In my experience, the first few months of the year indicate what lies ahead in 2025.
While I am not making any specific plans or promises, I am preparing for exciting future opportunities.
How has your March been so far?
If you would like to learn more about upcoming activities or explore collaboration opportunities, please feel free to reach out!